There were 180 startup candidates in 2019 at the first edition of the event Med’Innovant Africa, looking to the future with their inspiring projects. The event then assigned the companies Sen Or’Dur (plastic waste management solution in Senegal) and Promagric (Clinicplant application for the diagnosis of crop diseases and their treatment).
Given the success of the first edition, the Euroméditerranée Public Development Establishment will continue its policy of opening up to innovative nuggets from Africa in 2020 and thus reinforce its mission as a laboratory for experimentation.
If you want to find out more about the Med’Innovant Africa competition, download our companion app. Born2Invest’s team of journalists gathers the most interesting business news in a single mobile application. It’s impossible to keep up with everything you’re interested in, but our companion app will help you keep track of the important news. Our app is being updated throughout the day.
Which activities are concerned
For this year’s competition, the themes of energy, health, housing, mobility, the environment of course, or the world of connected objects or digital technology are targeted. These activities must contribute to social innovation, solidarity, urban management, cost control, and also focus on everything that contributes to the adaptable city, exchange and communication.
An opening towards Europe
The innovative strength of companies on the African continent is export-oriented. The European market, for example, is particularly in need of solutions for the reasoned development of territories, be it social or environmental.
Following the selections, the two future Med’Innovant Africa prize-winners will be granted access to the experimentation area set up by Euroméditerranée. They will test their technological intelligence live and deploy it in the heart of the Aix-Marseille metropolis. However, they could also go beyond this perimeter depending on opportunities and meetings with investors and industrial partners within the Euroméditerranée fabric.
The encouraging of innovative startups in Africa as a priority
Med’Innovant Africa is a unique opportunity for a reciprocal exchange where the conjunction of targeted innovation and investment allows the diffusion of technologies throughout Europe and Africa.
The exponential development of African economies proves the urgency of the adoption of these solutions for growth control. More than an emerging market, Africa is keeping pace with global economies and needs its talents to be supported. Detecting these accelerators and encouraging them is all the more urgent.
How to apply for Med’Innovant Africa
The competition is open to high-growth startups and SMEs based in Africa – including those incubated in France – whose activity has a strong impact on the development of sustainable and resilient territories. Companies can find out about the selection criteria and submit their applications until August 31st, 2020 on the dedicated website.
Four to five finalists will be invited to defend their case live at the Emerging Valley international summit, which brings together African Tech leaders, on December 7th and 8th 2020 at the Palais du Pharo in Marseille. Two distinctions will be awarded, the “Jury Prize” and the “Coup de Coeur Prize”, along with financial assistance of up to $7,900 (€7,000).
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in LePoint, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The first national clinical trial of a COVID-19 vaccine is now underway in Chile
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding...
New study on the economic impact of the pandemic in Burkina Faso
A recent study conducted in Burkina Faso showed that the pandemic has negative consequences on income and food security in...
Demecan launches an online cannabis shop for pharmacies
Demecan has opened an online shop for direct sales to pharmacies. Although the Berlin-based startup is the only German company...
Could the price of Bitcoin reach $100,000 by 2021?
PlanB analyst was able to determine not only the current and future scarcity/hardness of BTC, but also a possible Bitcoin...
Zadar Ventures Ltd. confirms much anticipated move into the booming VR & AR market segment
An exciting development in the world of virtual and augmented reality: Zadar Ventures Ltd. (TSX.V: ZAD, OTC: ZADDF Frankfurt: ZAV0.F)...
Africa5 days ago
Rwanda will build a nuclear research center
Featured6 days ago
Supply@Me Capital ready to close the first securitization of the overall €970 million program
Cannabis6 days ago
Medterra enters into a strategic partnership with Megalabs
Crypto7 days ago
The rise in Bitcoin’s price made 95% of the investment in cryptocurrency profitable